Research

Energy balance

Tirzepatide treatment was associated with a mean percentage weight change of -13.3% for 5 mg and -21.3% for 15 mg compared to placebo from randomization to 72 weeks among participants using weight-inducing medications in SURMOUNT-1.

Practitioners can consider tirzepatide as an effective option for weight loss in patients requiring weight-inducing medications.

StrongSupportsmedium confidence
The mean percentage weight change compared with placebo from randomization to 72 weeks for those treated with tirzepatide and using WI medication was -13.3% (95% CI, -16.0% to -10.7%) for 5 mg to -21.3% (95% CI, -23.9% to -18.7%) for 15 mg in SURMOUNT-1.
Rodolfo J. Galindo et al. · JAMA Network Open · 2026

Why this rating

Based on the post hoc analysis of phase 3 randomized clinical trials.

Source

Weight Changes With Tirzepatide and Concomitant Weight-Inducing Medications

Rodolfo J. Galindo et al. · JAMA Network Open · 2026

DOI 10.1001/jamanetworkopen.2026.3274

rct · n=2539
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →